Orthopaedic News and Research

RSS

Transdel Pharmaceuticals reports lower net loss of $0.9 million for first-quarter 2010

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced financial results for the quarter ended March 31, 2010. The Company also highlighted recent achievements.

14 May 2010

Folic acid supplement may improve blood flow in young amenorrheic runners

A study led by sports medicine researcher Anne Hoch, D.O. at The Medical College of Wisconsin in Milwaukee has found that oral folic acid may provide a safe and inexpensive treatment to improve vascular function in young female runners who are amenorrheic (not menstruating).

11 May 2010

28% of crashes attributed to cell phone talking, texting while driving

The American Academy of Orthopaedic Surgeons (AAOS) has joined forces with the Orthopaedic Trauma Association (OTA) on a public service announcement (PSA) urging drivers to NEVER text while driving. Simply put, texting is a deadly distraction that can cause accidents, severe orthopaedic injuries or even death. Orthopaedic surgeons not only treat, but want to prevent accidental traumas.

10 May 2010

Osteotech reports overall sequential revenue growth of 117% for first-quarter 2010

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the first quarter ended March 31, 2010.

10 May 2010

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

DJO Incorporated a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC ("DJOFL"), for the first quarter of 2010, ended April 3, 2010.

6 May 2010

Symmetry Medical's first-quarter 2010 revenues up 10.6%

Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2010 financial results for the three-month period ended April 3, 2010.

6 May 2010

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

BioInvent International AB and ThromboGenics NV announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.

6 May 2010

Obesity epidemic may be flattening out - still much to be done

The prevalence of childhood obesity might be stabilising in developed countries, but there is still much to be done to combat this major threat to health, according to a Seminar published on Online First and in an upcoming issue of The Lancet.

6 May 2010

ThromboGenics, BioInvent International report positive results from Phase II trial of TB-402 for VTE

ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.

6 May 2010

DGIMED ORTHO receives 510(k) clearance for DISTALOCK Titanium Femoral Intramedullary Nail system

DGIMED ORTHO, Inc. announced today that the company has received notification of clearance of its 510(k) submission for the DISTALOCKTM Titanium Femoral Intramedullary Nail system. In November 2009, the Company also received its initial clearance on the DISTALOCKTM Drill system with a stainless steel femoral IM nail.

6 May 2010

Surgeons can now customize artificial knee implants, prevent future revision surgeries

Throughout the years orthopedic surgeons have learned that one size does not fit all when it comes to joint replacements. Because of advancements in technology, surgeons can now customize artificial knee implants and prevent future revision surgeries.

4 May 2010

$Osteoporosis screening can reduce risk of future fractures$

Osteoporosis screening can reduce risk of future fractures

One in two women in the United States will have an osteoporosis-related fracture in her lifetime. However, according to a review article published in the May 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), only a few of these women will be tested and treated for osteoporosis, which if identified and treated, could dramatically decrease their risk of future fractures.

4 May 2010

Statins may improve longevity of hip replacement surgery

The use of statins - drugs commonly prescribed to help lower cholesterol levels - may play an important role in decreasing complications among patients undergoing total hip replacement (THR), according to a study published in the May 2010 issue of the Journal of Bone and Joint Surgery (JBJS).

4 May 2010

Non-Surgical Orthopaedics: Shoulder and upper extremity injuries are very common

Shoulder and upper extremity injuries are very common according to Non-Surgical Orthopaedics, P.C. Many of them result from years of cumulative injuries punctuated by a trauma such as a motor vehicle accident, falls, or sports injuries. These injuries cost consumers, their employers and insurance companies billions of dollars a year in treatment and productivity losses.

29 Apr 2010

$Ageing population prone to bone fractures drives South African joint replacement market$

Ageing population prone to bone fractures drives South African joint replacement market

The joint replacement market in South Africa is set to experience continued growth in the medium to long term, driven by an ageing population that is prone to cartilage degeneration and bone fractures. The introduction of innovative products with enhanced durability and longevity as well as safer operation techniques is further boosting growth in this market.

29 Apr 2010

New Zimmer Institute training center opened at TMT facility in Parsippany, New Jersey

Zimmer Holdings, Inc. today announced the opening of a new Zimmer Institute training center at its Trabecular Metal Technology facility in Parsippany, New Jersey. The Zimmer Institute at TMT will be Zimmer's first full-time BioSkills training center outside of the Zimmer Institute's headquarters in Warsaw, Indiana.

24 Apr 2010

Surgical treatment for certain injuries helps NFL athletes return to the game faster

The Bonati Spine Institute, the leading center for the patented Bonati Spine Procedures for minimally invasive laser spine surgery, reports that recent studies indicate that surgical intervention is the best treatment option for certain back injuries.

21 Apr 2010

LDR completes IDE study on Mobi-C cervical artificial disc

LDR, a privately held company with innovative spinal implants for non-fusion and fusion applications, announced completion of the 24-month follow-up phase of its two-level IDE study on the Mobi-C cervical artificial disc. Having previously finalized the 24-month follow-up phase of the one-level study earlier this year, LDR is now the first company to fully enroll and reach two-year follow-up on a concurrent one-level and two-level cervical artificial disc replacement study.

21 Apr 2010

Johnson & Johnson' first-quarter 2010 sales increase 4.0% to $15.6 billion

Johnson & Johnson today announced sales of $15.6 billion for the first quarter of 2010, an increase of 4.0% as compared to the first quarter of 2009. Operational results declined 0.1% and the positive impact of currency was 4.1%.

21 Apr 2010

Survey investigates procurement procedures, expenditures and consumption of medical devices

Centralised purchasing of medical devices does not reduce prices and medical devices are often undervalued as analyses focus only on the short-term financial and economic perspectives.

16 Apr 2010

Orthopaedic News and Research

Transdel Pharmaceuticals reports lower net loss of $0.9 million for first-quarter 2010

Folic acid supplement may improve blood flow in young amenorrheic runners

28% of crashes attributed to cell phone talking, texting while driving

Osteotech reports overall sequential revenue growth of 117% for first-quarter 2010

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

Symmetry Medical's first-quarter 2010 revenues up 10.6%

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

Obesity epidemic may be flattening out - still much to be done

ThromboGenics, BioInvent International report positive results from Phase II trial of TB-402 for VTE

DGIMED ORTHO receives 510(k) clearance for DISTALOCK Titanium Femoral Intramedullary Nail system

Surgeons can now customize artificial knee implants, prevent future revision surgeries

Osteoporosis screening can reduce risk of future fractures

Statins may improve longevity of hip replacement surgery

Non-Surgical Orthopaedics: Shoulder and upper extremity injuries are very common

Ageing population prone to bone fractures drives South African joint replacement market

New Zimmer Institute training center opened at TMT facility in Parsippany, New Jersey

Surgical treatment for certain injuries helps NFL athletes return to the game faster

LDR completes IDE study on Mobi-C cervical artificial disc

Johnson & Johnson' first-quarter 2010 sales increase 4.0% to $15.6 billion

Survey investigates procurement procedures, expenditures and consumption of medical devices

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News